Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Off-Label Promotion of Trileptal (Criminal Prosecution)

Novartis Pharmaceuticals Corporation (NPC) pleaded guilty to a misdemeanor violation of the Federal Food, Drug and Cosmetic Act and agreed to pay a $185 million fine related to the company’s off-label promotion of the epilepsy drug Trileptal. Novartis also resolved civil claims related to the marketing of Trileptal. (See Novartis AG instance, “Off-Label Promotion of Trileptal (Civil Litigation)”)

Misconduct Type
Health
Enforcement Agency
Health and Human Services
Contracting Party
None
Court Type
Criminal
Disposition
Pleaded Guilty
Date of Announcement
1/26/2010
Contractors Involved Penalty
Total
Novartis AG $185,000,000
Further Information Released
Criminal Information 11/30/2010
Entry of Plea 11/30/2010
Novartis Form 6-K (excerpt) 3/11/2010

See also:

Federal Contractor Misconduct Database